We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$94.2M
AUM Growth
-$8.29M
Cap. Flow
-$1.48M
Cap. Flow %
-1.57%
Top 10 Hldgs %
45.23%
Holding
75
New
2
Increased
22
Reduced
8
Closed
10

Top Buys

1
IOVA icon
Iovance Biotherapeutics
IOVA
+$1.31M
2
WBA
Walgreens Boots Alliance
WBA
+$1.06M
3
PD icon
PagerDuty
PD
+$954K
4
EOLS icon
Evolus
EOLS
+$673K
5
FCX icon
Freeport-McMoran
FCX
+$645K

Top Sells

1
CVS icon
CVS Health
CVS
+$1.38M
2
AMSC icon
American Superconductor
AMSC
+$1.25M
3
SWN
Southwestern Energy Company
SWN
+$1.12M
4
AMRX icon
Amneal Pharmaceuticals
AMRX
+$853K
5
ADSK icon
Autodesk
ADSK
+$818K

Sector Composition

1 Healthcare 38.49%
2 Financials 9.8%
3 Industrials 9.03%
4 Energy 8.36%
5 Materials 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COYA icon
51
Coya Therapeutics
COYA
$106M
$384K 0.41%
100,000
+40,000
+67% +$159K
FEMY icon
52
Femasys
FEMY
$8.91M
$373K 0.4%
6,250
-5,819
-48% -$60.8K
SMSI icon
53
Smith Micro Software
SMSI
$14.5M
$363K 0.39%
7,500
+1,875
+33% +$98.3K
KRON
54
DELISTED
Kronos Bio
KRON
$325K 0.34%
250,000
– –
ELDN icon
55
Eledon Pharmaceuticals
ELDN
$310M
$322K 0.34%
234,803
– –
GANX icon
56
Gain Therapeutics
GANX
$71.2M
$295K 0.31%
90,000
– –
EDSA icon
57
Edesa Biotech
EDSA
$63.5M
$264K 0.28%
59,657
+6,086
+11% +$35.9K
OGN icon
58
Organon & Co
OGN
$3.55B
$260K 0.28%
15,000
– –
BCDA icon
59
BioCardia
BCDA
$12.7M
$258K 0.27%
40,000
+17,133
+75% +$288K
LTRN icon
60
Lantern Pharma
LTRN
$38.3M
$256K 0.27%
75,000
– –
CADE
61
DELISTED
Cadence Bank
CADE
$212K 0.23%
10,000
– –
PVLA
62
Palvella Therapeutics
PVLA
$2.26B
$194K 0.21%
8,118
+1,243
+18% +$26.7K
CRIS icon
63
Curis
CRIS
$8.97M
$181K 0.19%
1,375
– –
NEUE
64
DELISTED
NeueHealth
NEUE
$154K 0.16%
25,715
– –
BCEL
65
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$91.3K 0.1%
350,000
– –
ADSK icon
66
Autodesk
ADSK
$46.2B
– –
-4,000
Closed -$818K
AMRX icon
67
Amneal Pharmaceuticals
AMRX
$5.77B
– –
-275,000
Closed -$853K
APA icon
68
APA Corp
APA
$12.3B
– –
-20,000
Closed -$683K
APLT
69
DELISTED
Applied Therapeutics
APLT
– –
-300,000
Closed -$384K
CVS icon
70
CVS Health
CVS
$136B
– –
-20,000
Closed -$1.38M
CYTK icon
71
Cytokinetics
CYTK
$11B
– –
-10,000
Closed -$326K
NWL icon
72
Newell Brands
NWL
$2.19B
– –
-30,000
Closed -$261K
NBSE
73
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
– –
-6,000
Closed -$11K
PRTK
74
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-250,000
Closed -$553K
SPPI
75
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-800,000
Closed -$768K
1 2
3

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q3 2023 Portfolio in Review

As of Q3 2023, CM Management held 75 positions worth $94.2M, down 8.1% from $103M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

CM Management's Q3 2023 filing shows 2 new, 22 increased, 8 reduced and 10 closed positions. Its largest new stake was Iovance Biotherapeutics: 200,000 shares worth $910K. The largest sale was CVS Health, an estimated $1.38M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 42% a quarter earlier, followed by Financials and Industrials.

  • CM Management's largest Q3 2023 buy was Iovance Biotherapeutics: 200,000 shares worth $910K.
  • CM Management added most to PagerDuty in Q3 2023, an estimated $954K increase.
  • CM Management's biggest Q3 2023 reduction was American Superconductor, cutting an estimated $1.25M.
  • CM Management fully exited CVS Health in Q3 2023, selling an estimated $1.38M.
  • CM Management's ten largest holdings make up 45% of its $94.2M portfolio in Q3 2023.
  • CM Management opened 2 new positions and closed 10 in Q3 2023.
  • CM Management's portfolio value fell 8.1% quarter-over-quarter to $94.2M.

Based on CM Management's 13F filing for Q3 2023, filed 7 Nov 2023.